Regenerative Medical Technology (RMTG) EBITDA Margin (2019 - 2026)
Regenerative Medical Technology's EBITDA Margin was 16.33% in Q2 2026, up 36.18 percentage points from -19.86% a year earlier and up 3.92 percentage points from the prior quarter.
Regenerative Medical Technology (RMTG) EBITDA Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regenerative Medical Technology's EBITDA Margin was 4.32% through Jun 30, 2026, down 5.03 percentage points year-over-year; for FY2025, it came in at -11.49%, down 18.84 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +801.15 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 7.35% in FY2024 (+24.16 pp), -16.81% in FY2023 (+50.64 pp), -67.45% in FY2022 (+2188.54 pp) and -2255.99% in FY2021 (-1443.35 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q4 2024.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +0.84 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2022 (a gain of 5421.47 percentage points); the worst was Q3 2021 (a drop of 5060.16 percentage points).
- Per Business Quant data, RMTG's EBITDA Margin in the three quarters before Q2 2026 was 12.41% (Q1 2026), -13.23% (Q4 2025) and -31.31% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Regenerative Medical Technology | 824,338.06 | -3.70 Mn | 2.58 Mn | 16.33% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.33% |
| Mar 31, 2026 | 12.41% |
| Dec 31, 2025 | -13.23% |
| Sep 30, 2025 | -31.31% |
| Jun 30, 2025 | -19.86% |
| Mar 31, 2025 | 13.69% |
| Dec 31, 2024 | 23.35% |
| Sep 30, 2024 | 11.00% |
| Jun 30, 2024 | -16.51% |
| Mar 31, 2024 | -3.49% |
| Dec 31, 2023 | -6.20% |
| Sep 30, 2023 | 3.65% |
| Jun 30, 2023 | -103.21% |
| Mar 31, 2023 | -2.24% |
| Dec 31, 2022 | -11.31% |
| Sep 30, 2022 | -33.17% |
| Jun 30, 2022 | -111.08% |
| Mar 31, 2022 | -172.59% |
| Dec 31, 2021 | -185.67% |
| Sep 30, 2021 | -5,454.64% |
Regenerative Medical Technology EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();